A Study of Camrelizumab Plus Chemotherapy in Combination With or Without Famitinib as Neoadjuvant Therapy in Participants With Triple Negative Breast Cancer (BCTOP-T-N01)
Clinical trial NCT05999149 · RECRUITING
Trial details
- NCT number
- NCT05999149
- Sponsor
- Fudan University
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-20
- Primary completion
- 2025-08-30
- Enrollment
- 424
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.